DIFFERENTIAL DIAGNOSIS
- Seizure is most commonly mistaken for syncope:
- Key differentiating factor is postictal confusion.
- Brief tonic movements and urinary incontinence may be seen with syncope.
- Metabolic disorders (e.g., hypoxemia, hyperventilation, hypoglycemia)
- Toxicologic
- Stroke
- Psychogenic syncope
- Malingering
- Breath-holding spells in children
TREATMENT
PRE HOSPITAL
- Oxygen
- Cardiac monitoring
- IV access
INITIAL STABILIZATION/THERAPY
- Advanced cardiac life support (ACLS) interventions for unstable patients
- Oxygen
- Cardiac monitoring
- IV access with normal saline fluid bolus in suspected hypovolemia
- Consider coma cocktail—dextrose, thiamine, and naloxone for persistent altered mental status
ED TREATMENT/PROCEDURES
- ACLS interventions for dysrhythmias
- Standard regimens for acute myocardial infarction
- Control BP for subarachnoid hemorrhage and aortic dissection
- Consider thrombolytics for submassive PE.
MEDICATION
- Dextrose: D
50
W 1 amp (50 mL or 25 g) IV (peds: D
25
W 2–4 mL/kg IV)
- Naloxone: 2 mg IV or IM (peds: 0.1 mg/kg)
- Thiamine: 100 mg IV or IM (peds: 50 mg)
FOLLOW-UP
DISPOSITION
Admission Criteria
- San Francisco Syncope Rule identifies patients at high risk for serious short-term outcomes (“CHESS”):
- History of
C
HF
- H
ematocrit <30%
- Abnormal
E
CG
- Patient complaint of
s
hortness of breath
- S
ystolic BP <90
- Other recommendations:
- Suspected cardiac syncope must be admitted to monitored bed
- GI bleeds consider intensive care unit bed
- Admit elderly patients with syncope.
Discharge Criteria
- Neutrally mediated syncope or orthostatic syncope from volume depletion may be evaluated on outpatient basis with close follow-up, if patient is reliable and has a good social structure.
- Driving restrictions until cleared
PEARLS AND PITFALLS
- Use of criteria such as the San Francisco Syncope Rule prevents unnecessary admissions.
- Do not assume vasovagal cause in syncope associated with headache or chest pain.
ADDITIONAL READING
- Brignole M, Alboni P, Benditt DG, et al. ESC guidelines on management (diagnosis and treatment) of syncope—update 2004. Executive summary.
Eur Heart J
. 2004;25(22):2054–2072.
- Kessler C, Tristano JM, De Lorenzo R, et al. The emergency department approach to syncope: Evidence-based guidelines and prediction rules.
Emerg Med Clin North Am.
2010;28:487–500.
- Massin MM, Bourguignont A, Coremans C, et al. Syncope in pediatric patients presenting to an emergency department.
J Pediatr
. 2004;145(2):223–228.
- Saccilotto RT, Nickel CH, Bucher HC, et al. San Francisco Syncope Rule to predict short-term serious outcomes: A systematic review.
CMAJ.
2011;183(15):E1116–1126.
- Yarlagadda S, Poma PA, Green LS, et al. Syncope during pregnancy.
Obstet Gynecol.
2010;115(2):377–380.
CODES
ICD9
- 337.01 Carotid sinus syndrome
- 427.89 Other specified cardiac dysrhythmias
- 780.2 Syncope and collapse
ICD10
- G90.01 Carotid sinus syncope
- R00.1 Bradycardia, unspecified
- R55 Syncope and collapse
SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (SIADH)
Matthew D. Bitner
BASICS
DESCRIPTION
- Most common cause of hyponatremia in hospitalized patients (and doubles inpatient mortality in some studies)
- A
water balance problem more
than 1 of sodium (Na) balance
- Normal regulation of water balance:
- Antidiuretic hormone (ADH):
- Integral controller of water balance
- Increases water permeability of the collecting tubules, resulting in free water reabsorption
- Synthesized by hypothalamus but secreted by posterior pituitary
- Water deprivation (increased plasma osmolality) stimulates secretion as sensed by:
- Osmoreceptors/atrial stretch receptors
- Carotid baroreceptors
- Aortic arch/pulmonary veins
- Hyponatremia:
- Mild
: Serum sodium <135 mEq/L
- Moderate
: Serum sodium <130 mEq/L
- Severe
: Serum sodium <125 mEq/L
- Excess extracellular water
relative
to Na
- Depletional hyponatremia:
- Sodium depletion can be caused by diet, GI losses, diuretic use, and renal or adrenal disease.
- Often accompanied by extracellular fluid volume depletion
- Hyponatremia associated with clinical signs of hypovolemia
- Increased Hct, BUN, Cr
- Urinary sodium excretion <20 mEq/L
- Dilutional hyponatremia:
- Increased extracellular water in presence of normal or increased total body sodium
- Can be caused by increased fluid intake (oral, IV), drugs, or medical conditions
- Euvolemia with edema
- Normal or decreased Hct, BUN, Cr
- Urinary sodium excretion >20 mEq/L
- Inappropriate ADH secretion is a form of dilutional hyponatremia.
- Definition of SIADH:
- ADH secretion in absence of hyperosmolality or hypovolemia
- Criteria for definition:
- Essential features:
- Hyponatremia
—despite correction for hyperglycemia, hyperproteinemia, or hyperlipidemia
- Euvolemia
—no clinical signs of volume depletion (orthostasis, tachycardia) or volume overload (edema, ascites)
- Hyposmolality
of the plasma—<275 mOsm/kg of water
- Normal renal, adrenal, and thyroid function
- No recent diuretic use
- Urine Osm >100 mOsm/kg of water
- Supplemental features:
- Plasma uric acid <4 mg/dL
- BUN <10 mg/dL
- FENa >1%
- Failure to correct hyponatremia after an infusion of normal saline (NS) 0.9%
- Abnormal water load test (inability to excrete ≥90% of a 20 mL/kg water load in 4 hr)
ETIOLOGY
- Malignant disorders:
- ADH-producing tumors
- Cancer (Small-cell lung, pancreatic, prostate)
- Pituitary tumors
- Thymoma
- Lymphoma
- Pulmonary disorders:
- Pneumonia
- TB
- Lung abscess
- COPD
- CNS disorders:
- Meningitis/encephalitis
- CVA
- Head injury
- Medications:
- Thiazides
- Chlorpropamide
- Vincristine
- Anticonvulsants (carbamazepine)
- Antidepressants (tricyclics, SSRIs)
- Antipsychotics
- NSAIDs
- Ecstasy (MDMA)
- Vasopressin analogs (DDAVP, oxytocin, vasopressin)
- Transient:
- Endurance exercise
- General anesthesia
- Pain
- Stress
- Other:
- Hereditary
- Positive-pressure ventilation
- HIV/AIDS
- Idiopathic
ALERT
Cerebral salt-wasting syndrome (CSWS) can mimic SIADH.
- Seen in patients with cerebral tumors or subarachnoid hemorrhage and in neurosurgical patients
- Etiology unclear
- Represents appropriate water resorption in the face of salt wasting (urine Na >30–40 mmol/L)
- Fluid restriction can help differentiate the 2:
- In SIADH: Hypouricemia will correct
- In CSWS: Hypouricemia will persist
- Treatment of CSWS may differ from that of SIADH:
- Infusion of NS
- May benefit from fludrocortisones therapy
DIAGNOSIS